Millions to benefit from medical device price cuts
Millions of Australians with private health insurance will benefit from price cuts to thousands of medical technologies treating heart and lung disease, diabetes, bone cancer, eye trauma, severe arthritis and more.
The cuts — which came into effect on 1 February 2020 — come in the wake of the Medical Technology Association of Australia’s (MTAA) agreement with Federal Health Minister Greg Hunt in 2017, which is on track to save $1.1 billion off the cost of medical devices by 2022.
“This agreement with government continues to help more Australians access more medical technology at less cost,” MTAA CEO Ian Burgess said. “That is what I call a win-win-win for patients, taxpayers and industry.
“Today’s announcement also debunks the long-held claim that the cost of individual medical technologies continue to rise, when the vast majority are actually falling in price.
“This is further evidence that when governments work with the medical technology sector, patients get a good deal more.”
Over three million medical devices were used to treat Australians with private health insurance last year alone.
Burgess commented that medical technology was evolving and becoming as much about improving lives as about saving them.
“Two of the biggest contributors to Australia’s ill health are inactivity and isolation — and the two are often linked, particularly as we get older.
“Increasingly, medical technology is being used not just to save lives, but keeping Australians more mobile, social, and now, working, for longer, which are all essential to the future health of our ageing population and economy.
“These medical technologies are also continuing to improve patient recovery and operating times, for less cost, meaning better outcomes for the health system and the budget,” he said.
| Condition | Med Tech | New price (Feb 2020) | Savings (Feb 2020) | Savings since agreement (2017) |
| Heart disease | Pacemaker | $35,132 | -$2848 | -$12,343 |
| Diabetes | Insulin pump | $8574 | -$451 | — |
| Severe arthritis (Hip) | Replacement joint | $8351 | -$393 | -$853 |
| Lung disease | Airflow valve system | $5686 | -$299 | -$614 |
| Bone cancer (leg) | Artificial bone | $7066 | -$181 | -$428 |
| Eye trauma | Artificial (glass) eye | $1741 | -$92 | -$189 |
Regulators step in as medicinal cannabis prescriptions soar
Concerned by reports of patients presenting to EDs with medicinal cannabis-induced psychosis,...
Diagnostic reference levels for mammography now a step closer
Australia is a step closer to diagnostic reference levels for mammography with the publication of...
$12m for homegrown heart disease and diabetes innovations
$12 million in federal funding has been announced for the development of new Australian-made...
